Product Information
ACAMPROSATE CALC DR 333 MG TAB is a generic product labeled by Bionpharma Inc., priced at $0.6077 per EA under NDC 69452035325. Its NADAC has been published 24 times since Jan 14, 2026.
Strength
333 mg/1
Manufacturer
Bionpharma Inc.NDC
69452035325
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACAMPROSATE CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA219904On Market Since
12/1/2025
Price Statistics
The NADAC for ACAMPROSATE CALC DR 333 MG TAB has been published 24 times since Jan 14, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6077 per EA |
|---|---|
| All-time high | $0.6218 (Feb 11, 2026) |
| All-time low | $0.5871 (May 20, 2026) |
| 52-week high | $0.6218 |
| 52-week low | $0.5871 |
| Median price | $0.6187 |
| Average price | $0.6083 |
| Largest weekly change | +4.0% (Jan 21, 2026) |
| Weeks tracked | 24 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACAMPROSATE CALC DR 333 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ACAMPROSATE CALC DR 333 MG TAB, manufactured by Bionpharma Inc., is $0.6077 per EA (NDC 69452035325), effective Jun 24, 2026.
How has the price of ACAMPROSATE CALC DR 333 MG TAB changed over time?
Over the history we have for it, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has held within roughly two percent of its current level. It has been tracked across 24 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for ACAMPROSATE CALC DR 333 MG TAB?
Since Jan 14, 2026, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has ranged from a low of $0.5871 (May 20, 2026) to a high of $0.6218 (Feb 11, 2026), with a median of $0.6187 per EA.
Are there cheaper alternatives to ACAMPROSATE CALC DR 333 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ACAMPROSATE CALC DR 333 MG TAB, but none are currently priced below it.
Who manufactures ACAMPROSATE CALC DR 333 MG TAB?
ACAMPROSATE CALC DR 333 MG TAB (NDC 69452035325) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification